WASHINGTON, DC - JANUARY 12:  U.S. House Budget Committee Chairman Rep. Tom Price (R-GA) addresses the second annual Conservative Policy Summit at the Heritage Foundation January 12, 2015 in Washington, DC. The theme for the summit this year is "Opportunity for All, Favoritism to None."  (Photo by Alex Wong/Getty Images)
Alex Wong/Getty Images
WASHINGTON, DC - JANUARY 12: U.S. House Budget Committee Chairman Rep. Tom Price (R-GA) addresses the second annual Conservative Policy Summit at the Heritage Foundation January 12, 2015 in Washington, DC. The theme for the summit this year is "Opportunity for All, Favoritism to None." (Photo by Alex Wong/Getty Images)
Now playing
01:51
Trump's HHS pick hates Obamacare
Senator Bernard Sanders (I-VT) asks questions to Betsy DeVos during her confirmation hearing for Secretary of Education before the Senate Health, Education, Labor, and Pensions Committee on Capitol Hill January 17, 2017 in Washington, DC. / AFP / Brendan Smialowski        (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
BRENDAN SMIALOWSKI/AFP/AFP/Getty Images
Senator Bernard Sanders (I-VT) asks questions to Betsy DeVos during her confirmation hearing for Secretary of Education before the Senate Health, Education, Labor, and Pensions Committee on Capitol Hill January 17, 2017 in Washington, DC. / AFP / Brendan Smialowski (Photo credit should read BRENDAN SMIALOWSKI/AFP/Getty Images)
Now playing
01:24
Sanders grills Trump nominee on GOP donations
Former ExxonMobil executive Rex Tillerson testifies during his confirmation hearing for Secretary of State before the Senate Foreign Relations Committee on Capitol Hill in Washington, DC, on January 11, 2017.
SAUL LOEB/AFP/AFP/Getty Images
Former ExxonMobil executive Rex Tillerson testifies during his confirmation hearing for Secretary of State before the Senate Foreign Relations Committee on Capitol Hill in Washington, DC, on January 11, 2017.
Now playing
02:24
Cabinet picks break with Trump on issues
Betsy DeVos, selected for Education Secretary by President-elect Donald Trump speaks during a rally, in Grand Rapids, Mich., Friday, Dec. 9, 2016. (AP Photo/Paul Sancya)
Paul Sancya/AP
Betsy DeVos, selected for Education Secretary by President-elect Donald Trump speaks during a rally, in Grand Rapids, Mich., Friday, Dec. 9, 2016. (AP Photo/Paul Sancya)
Now playing
01:43
DeVos: Trump described sexual assault in tape
rex tillerson non answers origwx bw_00000000.jpg
rex tillerson non answers origwx bw_00000000.jpg
Now playing
01:18
Rex Tillerson perfects the non-answer
WASHINGTON, DC - JANUARY 12:  U.S. House Budget Committee Chairman Rep. Tom Price (R-GA) addresses the second annual Conservative Policy Summit at the Heritage Foundation January 12, 2015 in Washington, DC. The theme for the summit this year is "Opportunity for All, Favoritism to None."  (Photo by Alex Wong/Getty Images)
Alex Wong/Getty Images
WASHINGTON, DC - JANUARY 12: U.S. House Budget Committee Chairman Rep. Tom Price (R-GA) addresses the second annual Conservative Policy Summit at the Heritage Foundation January 12, 2015 in Washington, DC. The theme for the summit this year is "Opportunity for All, Favoritism to None." (Photo by Alex Wong/Getty Images)
Now playing
03:49
Who is Tom Price?
Dr. Ben Carson Elizabeth Warren Trump benefit_00000000.jpg
Dr. Ben Carson Elizabeth Warren Trump benefit_00000000.jpg
Now playing
02:55
Warren to Carson: Will HUD benefit Trump?
CNN
Now playing
00:45
DeVos: Grizzlies can determine school gun laws
US Congressman Mike Pompeo, R-Kansas, is sworn in before testifying before the Senate (Select) Intelligence Committee on Capitol Hill in Washington, DC, January 12, 2017, on his nomination to be director of the Central Intelligence Agency (CIA) in the Trump administration. / AFP / JIM WATSON        (Photo credit should read JIM WATSON/AFP/Getty Images)
JIM WATSON/AFP/Getty Images
US Congressman Mike Pompeo, R-Kansas, is sworn in before testifying before the Senate (Select) Intelligence Committee on Capitol Hill in Washington, DC, January 12, 2017, on his nomination to be director of the Central Intelligence Agency (CIA) in the Trump administration. / AFP / JIM WATSON (Photo credit should read JIM WATSON/AFP/Getty Images)
Now playing
00:42
Pompeo: 'Pretty clear' Russia is behind hacks
mattis confirmation hearing
CNN
mattis confirmation hearing
Now playing
01:56
Mattis: I have confidence in intel community
Marco Rubio
CNN
Marco Rubio
Now playing
01:35
Rubio refuses to say if he will vote Tillerson
Ben Carson
CNN
Ben Carson
Now playing
01:06
Ben Carson in 60 seconds
cory booker jeff sessions testimony sot_00024814.jpg
cory booker jeff sessions testimony sot_00024814.jpg
Now playing
02:48
Cory Booker testifies against Sessions
john lewis sessions hrng
john lewis sessions hrng
Now playing
02:23
Rep. John Lewis: We don't want to go back
Now playing
01:27
Tillerson: Russia 'poses a danger'
Now playing
01:08
Rex Tillerson in 60 seconds

Story highlights

Price had drawn the ire of Democrats even before his stock trades

This year, Price bought and sold 12 healthcare stocks

(CNN) —  

Senate Democrats said Friday they will scrutinize the health industry stock trades of President-elect Donald Trump’s nominee to head the Department of Health and Human Services, saying they want to ensure that Rep. Tom Price didn’t break insider trading laws while sitting on a major health care subcommittee.

The Georgia Republican’s trades over the past four years will be front and center in his confirmation battle, according to a senior Democratic aide, who told CNN his party will try to determine if Price violated the Stock Act, a 2013 law designed to ensure lawmakers don’t profit on private data they get through their official work.

While there is no evidence that Price, who is an orthopedic surgeon, used inside information when he made multiple trades on health insurance, pharmaceutical and biotech stocks, Democrats and some outside ethics experts think the trades raise serious questions.

“Members of Congress should use their offices to work for the people they represent, not line their own pockets – and as Democrats and Republicans have agreed in the past, any possibility that an elected official has fallen short of that very basic standard must be taken seriously,” said Sen. Patty Murray, the top Democrat on the Senate health committee. “I expect a detailed and thorough examination of Congressman Price’s financial history in the coming days and weeks.”

A spokeswoman for Sen. Ron Wyden of Oregon, the top Democrat on the Finance Committee, which will conduct confirmation hearings for Price, said: “Potential conflicts of interest and impropriety raise serious questions about any nominee’s fitness for the job, and Senator Wyden will consider those issues as a part of the Finance Committee’s thorough vetting process.”

Phil Blando, a spokesman for Trump’s transition team, said Price “takes his obligation to uphold the public trust very seriously.”

He has “complied fully with all applicable laws and ethics rules governing his personal finances,” and if confirmed would comply with the law, Blando added.

Price, the House Budget Committee chairman, had drawn the ire of Democrats even before his stock trades – which were first reported by CQ/Roll Call and the Wall Street Journal – become public.

Democrats oppose Price because he is a leading GOP architect of repealing the Affordable Care Act, the health care law they champion. If he is confirmed at HHS, he will have a major role in determining how the law will be scrapped and what will replace it.

Democrats believe Price’s stock trades provide them an opening to convince the public, and perhaps a handful of Republicans, to oppose his confirmation. Hearings are not yet scheduled but are expected in January. Democrats then will have 48 seats compared to 52 for Republicans, meaning they will need to convince at least three Republicans to abandon Price if they are to defeat him.

This year, Price bought and sold 12 healthcare stocks, including big name biotech stocks like Biogen and Gilead Sciences as well as major pharmaceutical companies like Eli Lilly, Pfizer, and Bristol-Myers Squibb. He also traded in Aetna, the large health insurer; Athena Health, a health care services company; and CVS.

Price made these moves while a member of the Health subcommittee of the Ways and Means Committee, which among other responsibilities oversees Medicare. He also voted for the 21st Century Cures Act, which was signed into law by President Barack Obama earlier this month.

It will provide billions for medical research and clears red tape so the Food and Drug Administration can approve drugs faster, something that could be good for drug companies.

Most of Price’s trades were in the range of $1,000 to $15,000.

His biggest position in 2016 was taken in an Australian biotech company called Innate Immunotherapeutic. Disclosure records indicate Price invested between $50,000 and $100,000 in the company that includes on its board of directors Rep. Chris Collins, R-New York. Collins was the first member of Congress to endorse Trump and now works on Trump’s transition team.

“It shows a lack of judgment to be buying and selling health care company stocks if you are serving on a congressional committee that is making decisions that are going to impact the value of health care company stocks,” ethics expert Richard Painter told CNN. “In particular, if someone has access to confidential information, the (Securities and Exchange Commission) could investigate them.”

Painter, who was chief ethics lawyer for Republican President George W. Bush, said he expects Democrats will try to take advantage of Price’s decision to trade health stocks.

“I’m a lot more interested in this than if you paid your nanny tax. Nobody went to jail for not paying their nanny tax but they did for insider trading,” Painter said. “If he made these trades the burden is going to be on him to convince the committee and the Senate that he was not in possession of material non-public information.”

Price made scores of trades over the last four years. While many were in health stocks, most were not. He has a varied portfolio with interests in Facebook, Boeing, Phillips 66 and more.

CNN’s Ross Levitt contributed to this report.